Sionna Therapeutics Inc. (SION)
NASDAQ: SION
· Real-Time Price · USD
13.63
0.73 (5.66%)
At close: May 02, 2025, 3:59 PM
13.58
-0.37%
After-hours: May 02, 2025, 04:00 PM EDT
5.66% (1D)
| Bid | 12.34 |
| Market Cap | 601.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.45 |
| PE Ratio (ttm) | -9.4 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 14.87 |
| Volume | 204,361 |
| Avg. Volume (20D) | 230,306 |
| Open | 13.40 |
| Previous Close | 12.90 |
| Day's Range | 13.27 - 14.41 |
| 52-Week Range | 7.25 - 25.19 |
| Beta | 0.00 |
About SION
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator....
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 41
Stock Exchange NASDAQ
Ticker Symbol SION
Website https://www.sionnatx.com/
Analyst Forecast
According to 1 analyst ratings, the average rating for SION stock is "Buy." The 12-month stock price forecast is $32, which is an increase of 134.78% from the latest price.
Stock Forecasts
2 months ago · seekingalpha.com
U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO WeekTwo sizable companies and a handful of small Asian issuers were listed in the US this past week. Four small Asia-based issuers also went public in the US - EPWK Holdings, FBS Global, Plutus Financial ...